Related Experiment Video
Updated: Sep 20, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta
C Avolio1, F Giuliani, G M Liuzzi
1Neurology Unit, University of Foggia, Foggia, Italy. avolio@neurol.uniba.it
Abstract:
In Multiple Sclerosis (MS) pathology, early inflammation involves leukocyte migration across the blood-brain barrier (BBB) within the central nervous system. In this process, adhesion molecules (AMs), both membrane-bound and soluble-circulating forms, and matrix metalloproteinases (MMPs) certainly play a regulatory role. In MS, recombinant Interferon-beta (rIFNbeta) is effective in reducing gadolinium contrast-enhancing lesions on magnetic resonance imaging and this suggests that it may reduce BBB damage or even restore its integrity by different mechanisms that include interference with both AM and MMP pathways. This review will highlight the effects induced by rIFNbeta, both in vitro and in vivo, on cell-bound and soluble forms of AMs and on MMPs.
Insights
Recombinant Interferon-beta (rIFNbeta) impacts leukocyte migration in Multiple Sclerosis (MS) by modulating adhesion molecules and matrix metalloproteinases, potentially restoring blood-brain barrier integrity.
Area of Science:
- Neuroimmunology
- Molecular Biology
- Pharmacology
Background:
- Multiple Sclerosis (MS) involves leukocyte migration across the blood-brain barrier (BBB).
- Adhesion molecules (AMs) and matrix metalloproteinases (MMPs) regulate this inflammatory process.
- Recombinant Interferon-beta (rIFNbeta) is an effective MS treatment, suggesting BBB protective mechanisms.
Purpose of the Study:
- To review the effects of rIFNbeta on AMs and MMPs in MS pathology.
- To elucidate how rIFNbeta influences BBB integrity via these molecular pathways.
Main Methods:
- In vitro and in vivo studies examining rIFNbeta's impact.
- Analysis of both cell-bound and soluble forms of AMs.
- Assessment of MMP activity and expression.
Main Results:
- rIFNbeta influences cell-bound and soluble adhesion molecules.
- rIFNbeta affects matrix metalloproteinase activity.
- These effects suggest a role in modulating BBB permeability in MS.
Conclusions:
- rIFNbeta modulates key molecules involved in leukocyte trafficking across the BBB.
- Interference with AM and MMP pathways is a likely mechanism for rIFNbeta's therapeutic effect in MS.
- Further research into these pathways may reveal novel therapeutic strategies for MS.
More Related Videos
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Overview of Cell-Matrix Interactions
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Multiple Sclerosis l: Introduction
Role of Matrix Metalloproteases in Degradation of ECM
A...
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...